Paper39253
Pertussis vaccine--an analysis of benefits, risks and costs.
Koplan JP and 3 others. N Engl J Med, 1979. Cited by 120 papers, by iCite.
Cite this record
ConductScience Library. Pertussis vaccine--an analysis of benefits, risks and costs. Papers, record 39253. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39253
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cost-Benefit Analysis | Major topic |
| National Health Programs | Major topic |
| Pertussis Vaccine | Major topic |
| Vaccination | Major topic |
| Child | |
| Child, Preschool | |
| Decision Theory | |
| Encephalitis | |
| Encephalomyelitis, Acute Disseminated | |
| Europe | |
| Humans | |
| Infant | |
| Infant, Newborn | |
| Models, Theoretical | |
| Personal Health Services | |
| Risk | |
| United States | |
| Whooping Cough |
Source PubMed
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 120 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40756762 | From jurisdiction to veridiction: Expertise and economization of immunization policy in the United States. | Econ Soc | 2025 | https://conductscience.org/library/papers/40756762 | PubMed |
| 36919206 | The incidence, duration, risk factors, and age-based variation of missed opportunities to diagnose pertussis: A population-based cohort study. | Infect Control Hosp Epidemiol | 2023 | https://conductscience.org/library/papers/36919206 | PubMed |
| 32918682 | Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC). | Drug Saf | 2020 | https://conductscience.org/library/papers/32918682 | PubMed |
| 29856680 | Prevention of pertussis: An unresolved problem. | Hum Vaccin Immunother | 2018 | https://conductscience.org/library/papers/29856680 | PubMed |
| 27798531 | 20 Years of Public Health Economics and Decision Sciences at the US Centers for Disease Control and Prevention: The CDC Steven M. Teutsch Prevention Effectiveness Fellowship, 1995-2015. | J Public Health Manag Pract | 2017 | https://conductscience.org/library/papers/27798531 | PubMed |
| 25747269 | Pertussis post-exposure prophylaxis among household contacts: a cost-utility analysis. | PLoS One | 2015 | https://conductscience.org/library/papers/25747269 | PubMed |
| 24986039 | Decision-analytic models: current methodological challenges. | Pharmacoeconomics | 2014 | https://conductscience.org/library/papers/24986039 | PubMed |
| 21852883 | Vaccination and the onset of dravet syndrome. | Epilepsy Curr | 2011 | https://conductscience.org/library/papers/21852883 | PubMed |
| 20976213 | Cost-effectiveness of adolescent pertussis vaccination for the Netherlands: using an individual-based dynamic model. | PLoS One | 2010 | https://conductscience.org/library/papers/20976213 | PubMed |
| 18976924 | Post-vaccination encephalomyelitis: literature review and illustrative case. | J Clin Neurosci | 2008 | https://conductscience.org/library/papers/18976924 | PubMed |
| 17619922 | Transgenic tomatoes express an antigenic polypeptide containing epitopes of the diphtheria, pertussis and tetanus exotoxins, encoded by a synthetic gene. | Plant Cell Rep | 2007 | https://conductscience.org/library/papers/17619922 | PubMed |
| 17067190 | Recent developments in decision-analytic modelling for economic evaluation. | Pharmacoeconomics | 2006 | https://conductscience.org/library/papers/17067190 | PubMed |
| 15831828 | Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. | Clin Microbiol Rev | 2005 | https://conductscience.org/library/papers/15831828 | PubMed |
| 11861623 | The contributions of biomedical informatics to the fight against bioterrorism. | J Am Med Inform Assoc | 2002 | https://conductscience.org/library/papers/11861623 | PubMed |
| 11666109 | Evaluating the benefits of increasing measles immunization rates. | Health Serv Res | 2001 | https://conductscience.org/library/papers/11666109 | PubMed |
| 11465300 | Economic evaluation of a new acellular vaccine for pertussis in Canada. | Pharmacoeconomics | 2001 | https://conductscience.org/library/papers/11465300 | PubMed |
| 10885208 | Fundamentals of clinical economics in health interventions. | Indian J Pediatr | 2000 | https://conductscience.org/library/papers/10885208 | PubMed |
| 9625337 | Economic evaluation of pertussis prevention by whole-cell and acellular vaccine in Germany. | Eur J Pediatr | 1998 | https://conductscience.org/library/papers/9625337 | PubMed |
| 8329146 | Current thoughts on the risks and benefits of immunisation. | Drug Saf | 1993 | https://conductscience.org/library/papers/8329146 | PubMed |
| 7262958 | Strategy for childhood immunization in India. Prioritization of vaccines. | Indian J Pediatr | 1980 | https://conductscience.org/library/papers/7262958 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39253
GET https://conductscience.org/api/papers/v1/39253/cited_by?page=2